New Investigator Research Grant Program

B-cell acute lymphoblastic leukemia (B-ALL) is a blood cancer that can be difficult to treat when it returns after therapy. In many cases, leukemia cells continue to grow because they receive strong signals to survive and remain in an immature state, which makes them harder to eliminate. New treatment strategies are urgently needed for patients with resistant or relapsed disease. This project aims to better understand how these internal signals control leukemia behavior and to develop new ways to interfere with them. We will study how leukemia cells respond when signals that support their growth are blocked while, at the same time, signals that drive them to mature into more normal cells are activated. By combining these approaches, we hope to both limit leukemia growth and reduce its ability to persist after treatment. If successful, this work could lead to new, more effective treatment strategies for patients with B-ALL and provide new insights into how blood cancers can be treated by changing how cancer cells grow and develop.